• 1
    Lepor H, Rigauld G. the efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism. J Urol 1990; 143: 5337
  • 2
    Han M, Alfert H, Partin AW. Retropubic and suprapubic open prostatectomy. In WalshPC, RetikA, VaughanED, WeinAJ eds, Campbell’s Urology. 8th edn. Chapter 41. Philadelphia: WB Saunders, 2002: 1423133
  • 3
    Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 2437
  • 4
    Serretta V, Morgia G, Fondacaro L et al. Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology 2002; 60: 6237
  • 5
    Schulman CC, Zlotta AR, Rasor JS, Hourriez L, Noel JC, Edwards SD. Transurethral needle ablation (TUNA). safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 1993; 24: 41523
  • 6
    Kaplan SA, Te AE. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 1995; 45: 56672
  • 7
    Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 1992; 69: 6038
  • 8
    Kabalin JN, Bite G, Doll S. Neodymium:YAG laser coagulation prostatectomy. 3 years of experience with 227 patients. J Urol 1996; 155: 1815
  • 9
    Muschter R, Hofstetter A. Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol 1995; 9: 12935
  • 10
    Bihrle R, Forster RS, Sanghvi NT, Donohue JP, Hood PJ. High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experiences. J Urol 1994; 151: 12715
  • 11
    Blute ML, Tomera KM, Hellerstein DK et al. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. J Urol 1993; 150: 15916
  • 12
    Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 1996; 48: 57583
  • 13
    Kuntzman RS, Malek RS, Barrett DM, Bostwick D. G. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997; 49: 7038
  • 14
    Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998; 51: 2546
  • 15
    Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003; 17: 936
  • 16
    Barber NJ, Zhu G, Donohue JF, Thompson PM, Walsh K, Muir GH. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate. Urology 2006; 67: 803
  • 17
    Chandrasekera SK, Barber NJ, Thompson PM, Muir GH. GreenLight PVP safety and efficacy in large prostates >100 mls. Eur Urol 2005; 4 (Suppl.): 256
  • 18
    Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004; 64: 11559
  • 19
    Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005; 173: 15860
  • 20
    Van Melick HH, Van Venrooij GE, Boon TA. Laser prostatectomy in patients on anticoagulant therapy or with bleeding disorders. J Urol 2003; 170: 18515
  • 21
    Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray Bedi O. Short term outcomes of high power (80W) potassium-titanyl-phosphate laser vaporisation of the prostate. European Urol 2005; 48: 60813
  • 22
    Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005; 174: 13448
  • 23
    Peterson MD, Matlaga BR, Kim SC et al. Holmium laser enucleation of the prostate for men with urinary retention. J Urol 2005; 174: 9981001
  • 24
    Anson K. Could the latest generation of potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol 2004; 14: 279
  • 25
    Barber NJ, Muir GH. High-power KTP laser prostatectomy. the new challenge to transurethral resection of the prostate. Curr Opin Urol 2004; 14: 215
  • 26
    Te AE. The development of laser prostatectomy. BJU Int 2004; 93: 2625
  • 27
    Agirbas I, Tatar M, Kisa A. Benign prostatic hyperplasia. cost and effectiveness of three alternative surgical treatment methods used in a Turkish hospital. J Med Syst 2005; 29: 48792
  • 28
    Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of the prostate: a size-independent new ‘gold standard’. Urology 2005; 66 (Suppl.): 10813
  • 29
    Seki N, Mochida O, Kinukawa N, Sagiyama K, Naito S. Holmium laser enucleation for prostatic adenoma. analysis of learning curve over the course of 70 consecutive cases. J Urol 2003; 170: 184750
  • 30
    Mariano MB, Tefilli MV, Graziottin TM, Morales CM, Goldraich IH. Laparoscopic prostatectomy for benign prostatic hyperplasia – a six-year experience. Eur Urol 2006; 49: 12731
  • 31
    Porpiglia F, Terrone C, Renard J et al. Transcapsular adenomectomy (Millin): a comparative study, extraperitoneal laparoscopy versus open surgery. Eur Urol 2006; 49: 1206